Evidence map›Paper›PMID 25117067›Full record

ArticleThe oncologist2014

The association of hospital spending intensity and cancer outcomes: a population-based study in an Asian country.

Ting-Shou Chang, Kuang-Yung Huang, Chun-Ming Chang, Chun-Hsuan Lin, Yu-Chieh Su, Ching-Chih Lee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The oncologist, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Association Between Spending and Outcomes for Patients With Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Review
  2. An Empirical Investigation of "Physician Congestion" in U.S. University Hospitals.International journal of environmental research and public health · 2019
    Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ting-Shou ChangDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China.
Kuang-Yung HuangDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China.
Chun-Ming ChangDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China.
Chun-Hsuan LinDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China.
Yu-Chieh SuDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China hematcd@hotmail.com hepatoma@ms3.hinet.net.
Ching-Chih LeeDepartment of Otolaryngology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China; National Defense Medical Center, Taipei, Taiwan, Republic of China; Institute of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China; Division of Rheumatology, Department of Internal Medicine, Department of Surgery, Department of Medical Research, Division of Hematology-Oncology, Department of Internal Medicine, Department of Otolaryngology, Center for Clinical Epidemiology and Biostatistics, and Cancer Center, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Republic of China; School of Medicine, Tzu Chi University, Hualian, Taiwan, Republic of China; Department of Life Science and Institute of Molecular Biology, National Chung Cheung University, Chiayi, Taiwan, Republic of China hematcd@hotmail.com hepatoma@ms3.hinet.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferent results are reported for the relationship between regional variation in medical spending and disease prognosis for acute illness and for cancer. Our objective was to investigate the association between hospital medical care spending intensity and mortality rates in cancer patients.

methodsA total of 80,597 patients with incident cancer diagnosed in 2002 were identified from the National Health Insurance Research Database of Taiwan, Republic of China. The Cox proportional hazards model was used to compare the 5-year survival rates of patients treated at hospitals with different spending intensities after adjusting for possible confounding and risk factors.

resultsAfter adjustment for patient characteristics, treatment modality, and hospital volume, an association was found between lower hospital spending intensity and poorer survival rates. The 5-year survival rate expressed by hazard ratios was 1.36 (95% confidence interval [CI]: 1.30-1.43, p < .001) for colorectal cancer, 1.18 (95% CI: 1.08-1.29, p < .001) for lung cancer, 1.13 (95% CI: 1.05-1.22, p = .002) for hepatoma, 1.16 (95% CI: 1.07-1.26, p < .001) for breast cancer, and 1.23 (95% CI: 1.10-1.39, p = .001) for prostate cancer.

conclusionOur preliminary findings indicate that higher hospital spending intensity was associated with lower mortality rates in patients being treated for lung cancer, breast cancer, colorectal cancer, prostate cancer, hepatoma, or head and neck cancer. The cancer stages were unavailable in this series, and more research linked with the primary data may be necessary to clearly address this issue.

Indexed as

PrognosisAdultAgedAsiaBreast NeoplasmsColorectal NeoplasmsCost-Benefit AnalysisFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingProportional Hazards ModelsSurvival RateCancerCox proportional hazards modelHospital spending intensitySurvival rate

Identifiers

PMID25117067
PMCPMC4153453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.